Clinical Trial

Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated May 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to test TCR-like CAR-T in the Treatment of MSLN positive Ovarian Cancer. The main question it aims to answer are: the safety and efficacy of TCR-like CAR-T in the Treatment of MSLN positive Ovarian Cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-26; most recent amendment 2025-03-26.
Status change: Recruiting → Active, Not Recruiting 2025-03-06
Trial Details
NCT Number NCT05963100
Lead Sponsor Zhongda Hospital
Conditions Safety and Efficacy of TCR-like CAR-T
Enrollment 10 participants
Start Date 2023-08-07
Primary Completion 2026-05-16 (estimated)
Study Completion 2026-05-16 (estimated)
Updated on ClinicalTrials.gov 2025-04-02